График акции Sensei Biotherapeutics, Inc.
Расширенный график
Простой график
О компании
Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. подробнее| EBITDA | -0.0124 |
|---|---|
| EV/EBITDA | -1.28 |
| IPO date | 2021-02-04 |
| ISIN | US81728A1088 |
| Industry | Biotechnology |
| P/BV | 1 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.senseibio.com |
| Цена ао | 1.04 |
| Число акций ао | 0.02795 млрд |
| Изменение цены за день: | +3.92% (0.4792) |
|---|---|
| Изменение цены за неделю: | +10.69% (0.4499) |
| Изменение цены за месяц: | -10.35% (0.5555) |
| Изменение цены за 3 месяца: | -10.35% (0.5555) |
| Изменение цены за полгода: | -20.96% (0.6301) |
| Изменение цены за год: | -28.03% (0.692) |
| Изменение цены за 3 года: | -91.31% (5.73) |
| Изменение цены за 5 лет: | 0% (0.498) |
| Изменение цены за 10 лет: | 0% (0.498) |
| Изменение цены с начала года: | -28.03% (0.692) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Newtyn Management, LLC | 1572023 | 6.27 |
| Vanguard Group Inc | 573651 | 2.29 |
| Renaissance Technologies, LLC | 143508 | 0.57 |
| Geode Capital Management, LLC | 136318 | 0.54 |
| Bridgeway Capital Management, Inc. | 112900 | 0.45 |
| Duquesne Family Office LLC | 100000 | 0.4 |
| Bank of America Corporation | 90788 | 0.36 |
| Millennium Management LLC | 38295 | 0.15 |
| Blackrock Inc. | 34813 | 0.14 |
| Northern Trust Corporation | 26049 | 0.1 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Mr. John K. Celebi M.B.A. | President, CEO & Director | 882.28k | 1972 (52 года) |
| Dr. Edward Van der Horst Ph.D. | Chief Scientific Officer | 630.81k | 1974 (50 лет) |
| Ms. Lora Pike | Vice President of Investor Relations & Communications | N/A | |
| Mr. Christopher W. Gerry J.D. | Senior VP, General Counsel & Secretary | N/A | |
| Ms. Stephanie Krebs M.B.A., M.S. | Chief Business Officer | N/A | 1978 (46 лет) |
| Dr. Aaron Weitzman FACP, M.D., Ph.D. | Chief Medical Officer | N/A | |
| Mr. Josiah Craver | Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer |
Адрес: United States, Rockville. MD, 1405 Research Boulevard - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.senseibio.com
Сайт: https://www.senseibio.com
